Therapeutic Efficacy of Artemether-Lumefantrine in Treating Un-complicated Plasmodium falciparum Malaria in Children at Wad-Medani, Sudan
Article Sidebar
Dimensions.ai Badge
Main Article Content
Abstract
Malaria remains a significant public health concern in Sudan, particularly among children, with Plasmodium falciparum as the dominant species. Artemether-Lumefantrine (AL) is the recommended first-line treatment for uncomplicated malaria; however, rising treatment failure rates necessitate further evaluation. This study assessed the therapeutic efficacy of AL in children aged 6 months to 16 years at Wad-Medani Pediatric Teaching Hospital, Gezira State. A prospective single-arm interventional study was conducted, enrolling 80 patients and following 70 through a 28-day treatment regimen. Clinical assessments, parasitological responses, and adherence evaluations were performed. The results showed a cure rate of 91.5%, with significant adherence-related outcomes (p<0.05). Early treatment failure (ETF) was observed in 5% of cases, with no late clinical or parasitological failures reported. Clinical pharmacist interventions improved awareness and adherence among healthcare providers and caregivers. The study concluded that AL remains highly effective for treating uncomplicated malaria in Sudan, although targeted interventions to enhance adherence are critical for sustained efficacy.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
World Health Organization. (2020). The potential impact of health service disruptions on the burden of malaria: A modelling analysis for countries in sub-Saharan Africa. Geneva: World Health Organization.
Abuaku, B., Duah-Quashie, N. O., Quashie, N., Gyasi, A., Afriyie, P. O., Owusu-Antwi, F., Ghansah, A., Malm, K. L., Bart-Plange, C., & Koram, K. A. (2021). Trends and predictive factors for treatment failure following artemisinin-based com-bination therapy among children with uncomplicated malaria in Ghana: 2005–2018. BMC Infectious Diseases, 21(1), 1255. DOI: https://doi.org/10.1186/s12879-021-06961-4
Ogouyèmi-Hounto, A., Azandossessi, C., Lawani, S., Damien, G., de Tove, Y. S., Remoue, F., & Kinde Gazard, D. (2016). Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin. Malaria Journal, 15, 37. DOI: https://doi.org/10.1186/s12936-016-1091-2
Musa, E. A. M., Harron, H. M., & Maatoug, M. M. A. (2019). Assessment of medical doctors’ adherence to national protocol for treatment of severe pneumonia in under-five children admitted to Wad-Medani pediatric teaching hospital, Gezira State, Sudan (2018). Clinical Practice, 16(S1), 1381–1388. DOI: https://doi.org/10.37532/fmcp.2019.16(S1).1381-1388
WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group. (2015). Arteme-ther-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: A systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data. BMC Medicine, 13, 227. DOI: https://doi.org/10.1186/s12916-015-0456-7
Raobela, O., Andriantsoanirina, V., Rajaonera, D. G., Rakotomanga, T. A., Rabearimanana, S., Ralinoro, F., Ménard, D., & Ratsimbasoa, A. (2018). Efficacy of artesunate-amodiaquine in the treatment of Plasmodium falciparum uncomplicated malaria in Madagascar. Malaria Journal, 17(1), 284 DOI: https://doi.org/10.1186/s12936-018-2440-0
Abamecha, A., Yilma, D., Addisu, W., El-Abid, H., Ibenthal, A., Noedl, H., Yewhalaw, D., Moumni, M., & Abdissa, A. (2020). Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Chewaka District, Ethiopia. Malaria Journal, 19(1), 240. DOI: https://doi.org/10.1186/s12936-020-03307-4
Tesfaye, M., Assefa, A., Hailgiorgis, H., Gidey, B., Mohammed, H., Tollera, G., Tasew, G., Assefa, G., Bekele, W., & Mamo, H. (2024). Therapeutic efficacy and safety of artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria treatment in Metehara, Central-east Ethiopia. Malaria Journal, 23(1), 184. Sinclair, D., Zani, B., Donegan, S., Olliaro, P., & Garner, P. (2009). Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database of Systematic Reviews, 2009(3), CD007483. DOI: https://doi.org/10.1186/s12936-024-04991-2
Westercamp, N., Owidhi, M., Otieno, K., Chebore, W., Buff, A. M., Desai, M., Kariuki, S., & Samuels, A. M. (2022). Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum ma-laria among children in Western Kenya, 2016 to 2017. Antimicrobial Agents and Chemotherapy, 66(9), e00207-22. DOI: https://doi.org/10.1128/aac.00207-22
Oyebola, K. M., Ligali, F. C., Owoloye, A. J., Aina, O. O., Alo, Y. M., Erinwusi, B., Olufemi, M. J., & Salako, B. L. (2024). Assessing the therapeutic efficacy of artemether-lumefantrine for uncomplicated malaria in Lagos, Nigeria: A com-prehensive study on treatment response and resistance markers. Malaria Jour-nal, 23, 261. https://doi.org/10.1186/s12936-024-05088-6 DOI: https://doi.org/10.1186/s12936-024-05088-6
Phyo, A. P., & Nosten, F. (2018). The artemisinin resistance in Southeast Asia: An imminent global threat to malaria elimination. In IntechOpen. DOI: https://doi.org/10.5772/intechopen.76519
World Health Organization. (2015). Guidelines for the treatment of malaria (3rd ed.). World Health Organization.
Pryce, J., Taylor, M., Fox, T., & Hine, P. (2022). Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database of Systematic Reviews, 6(6), CD006404 DOI: https://doi.org/10.1002/14651858.CD006404.pub4